Related references
Note: Only part of the references are listed.Revving the CAR-Combination strategies to enhance CAR T cell effectiveness
Rajat Bansal et al.
BLOOD REVIEWS (2021)
Allogeneic Vγ9Vδ2 T-cell immunotherapy exhibits promising clinical safety and prolongs the survival of patients with late-stage lung or liver cancer
Yan Xu et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2021)
Current Concepts and Advances in Graft-Versus-Host Disease Immunology
Geoffrey R. Hill et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 39 (2021)
Graft-versus-host disease prophylaxis: Pathophysiology-based review on current approaches and future directions
Nuria Martinez-Cibrian et al.
BLOOD REVIEWS (2021)
Mesenchymal stem cells and cancer therapy: insights into targeting the tumour vasculature
Surendar Aravindhan et al.
CANCER CELL INTERNATIONAL (2021)
Will allogeneic CAR T cells for CD19+ malignancies take autologous CAR T cells 'off the shelf'?
Amanda M. DiNofia et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2021)
CAR-NK cells from engineered pluripotent stem cells: Off-the-shelf therapeutics for all patients
Shi-Jiang Lu et al.
STEM CELLS TRANSLATIONAL MEDICINE (2021)
A Review of Chimeric Antigen Receptor T-Cell Therapy for Myeloma and Lymphoma
Shebli Atrash et al.
ONCOTARGETS AND THERAPY (2021)
Natural Killer Cells Generated From Human Induced Pluripotent Stem Cells Mature to CD56brightCD16+NKp80+/- In-Vitro and Express KIR2DL2/DL3 and KIR3DL1
Johanna Euchner et al.
FRONTIERS IN IMMUNOLOGY (2021)
Generation of hypoimmunogenic T cells from genetically engineered allogeneic human induced pluripotent stem cells
Bo Wang et al.
NATURE BIOMEDICAL ENGINEERING (2021)
Engineering the next generation of CAR-NK immunotherapies
Alexander Biederstaedt et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2021)
DL4-μbeads induce T cell lineage differentiation from stem cells in a stromal cell-free system
Ashton C. Trotman-Grant et al.
NATURE COMMUNICATIONS (2021)
Cell Therapy With TILs: Training and Taming T Cells to Fight Cancer
Amrendra Kumar et al.
FRONTIERS IN IMMUNOLOGY (2021)
Engineering stem cells for cancer immunotherapy
Yan-Ruide Li et al.
TRENDS IN CANCER (2021)
Regeneration of antigen-specific T cells by using induced pluripotent stem cell (iPSC) technology
Hiroshi Kawamoto et al.
INTERNATIONAL IMMUNOLOGY (2021)
Development of allogeneic HSC-engineered iNKT cells for off-the-shelf cancer immunotherapy
Yan-Ruid Li et al.
CELL REPORTS MEDICINE (2021)
Chimeric Antigen Receptor-Engineered Natural Killer (CAR NK) Cells in Cancer Treatment; Recent Advances and Future Prospects
Reza Elahi et al.
STEM CELL REVIEWS AND REPORTS (2021)
CRISPR/Cas9 revitalizes adoptive T-cell therapy for cancer immunotherapy
Sasan Ghaffari et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)
Armored CAR T-Cells: The Next Chapter in T-Cell Cancer Immunotherapy
Elizabeth R. Hawkins et al.
BIOLOGICS-TARGETS & THERAPY (2021)
Translating gammadelta (gamma delta) T cells and their receptors into cancer cell therapies
Zsolt Sebestyen et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Pluripotent stem cell-derived NK cells with high-affinity noncleavable CD16a mediate improved antitumor activity
Huang Zhu et al.
BLOOD (2020)
'Off-the-shelf' allogeneic CAR T cells: development and challenges
S. Depil et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
NK cells for cancer immunotherapy
Noriko Shimasaki et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors
Enli Liu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
MAIT Cells Promote Tumor Initiation, Grow and Metastases via Tumor MR1
Juming Yan et al.
CANCER DISCOVERY (2020)
Therapeutic Potential of Mesenchymal Stem Cells for Cancer Therapy
Abdelkrim Hmadcha et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2020)
Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation
Olaf Penack et al.
Lancet Haematology (2020)
Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease
Robert Zeiser et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Cancer immunotherapy with γδ T cells: many paths ahead of us
Dieter Kabelitz et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
License to Kill: When iNKT Cells Are Granted the Use of Lethal Cytotoxicity
Angelica Diaz-Basabe et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Use of Cell and Genome Modification Technologies to Generate Improved Off-the-Shelf CAR T and CAR NK Cells
Michael A. Morgan et al.
FRONTIERS IN IMMUNOLOGY (2020)
An Update on the Molecular Basis of Phosphoantigen Recognition by Vγ9Vδ2 T Cells
Thomas Herrmann et al.
CELLS (2020)
Sustainable Tumor-Suppressive Effect of iPSC-Derived Rejuvenated T Cells Targeting Cervical Cancers
Tadahiro Honda et al.
MOLECULAR THERAPY (2020)
Genome engineering of induced pluripotent stem cells to manufacture natural killer cell therapies
Keerthana Shankar et al.
STEM CELL RESEARCH & THERAPY (2020)
Anti-GD2 CAR-NKT cells in patients with relapsed or refractory neuroblastoma: an interim analysis
Andras Heczey et al.
NATURE MEDICINE (2020)
Umbilical Cord Blood and iPSC-Derived Natural Killer Cells Demonstrate Key Differences in Cytotoxic Activity and KIR Profiles
Benjamin H. Goldenson et al.
FRONTIERS IN IMMUNOLOGY (2020)
Genome-edited, donor-derived allogeneic anti-CD19 chimeric antigen receptor T cells in paediatric and adult B-cell acute lymphoblastic leukaemia: results of two phase 1 studies
Reuben Benjamin et al.
LANCET (2020)
Next-generation cell therapies: the emerging role of CAR-NK cells
Rafet Basar et al.
BLOOD ADVANCES (2020)
Off-the-Shelf Allogeneic T Cell Therapies for Cancer: Opportunities and Challenges Using Naturally Occurring Universal Donor T Cells
Cynthia Perez et al.
FRONTIERS IN IMMUNOLOGY (2020)
iPSC-derived NK cells maintain high cytotoxicity and enhance in vivo tumor control in concert with T cells and anti-PD-1 therapy
Frank Cichocki et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Roles of NKT cells in cancer immunotherapy
Eun-Ah Bae et al.
ARCHIVES OF PHARMACAL RESEARCH (2019)
Activated and Exhausted MAIT Cells Foster Disease Progression and Indicate PoorOutcomein Hepatocellular Carcinoma
Meng Duan et al.
CLINICAL CANCER RESEARCH (2019)
CAR T-cells: costs, comparisons, and commentary
Annette E. Hay et al.
JOURNAL OF MEDICAL ECONOMICS (2019)
iNKT cells and hematopoietic stem cell transplantation: Two-phase activation of iNKT cells may improve outcome
Mohammad Fereidouni et al.
CLINICAL IMMUNOLOGY (2019)
α-GalCer and iNKT Cell-Based Cancer Immunotherapy: Realizing the Therapeutic Potentials
Yingting Zhang et al.
FRONTIERS IN IMMUNOLOGY (2019)
Adoptive cell therapy using engineered natural killer cells
Katayoun Rezvani
BONE MARROW TRANSPLANTATION (2019)
NKT Cells Coexpressing a GD2-Specific Chimeric Antigen Receptor and IL15 Show Enhanced In Vivo Persistence and Antitumor Activity against Neuroblastoma
Xin Xu et al.
CLINICAL CANCER RESEARCH (2019)
The biology and functional importance of MAIT cells
Dale Godfrey et al.
NATURE IMMUNOLOGY (2019)
CAR T cell therapy: A new era for cancer treatment
Rimjhim Mohanty et al.
ONCOLOGY REPORTS (2019)
Development of Hematopoietic Stem Cell-Engineered Invariant Natural Killer T Cell Therapy for Cancer
Yanni Zhu et al.
CELL STEM CELL (2019)
Invariant NKT cells facilitate cytotoxic T-cell activation via direct recognition of CD1d on T cells
Yingyu Qin et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2019)
Highly efficient multiplex human T cell engineering without double-strand breaks using Cas9 base editors
Beau R. Webber et al.
NATURE COMMUNICATIONS (2019)
Engineered T Cell Therapy for Cancer in the Clinic
Lijun Zhao et al.
FRONTIERS IN IMMUNOLOGY (2019)
CRISPR-Cas9 disruption of PD-1 enhances activity of universal EGFRvIII CAR T cells in a preclinical model of human glioblastoma
Bryan D. Choi et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Toward the development of true off-the-shelf synthetic T-cell immunotherapy
Shoichi Iriguchi et al.
CANCER SCIENCE (2019)
Organoid-Induced Differentiation of Conventional T Cells from Human Pluripotent Stem Cells
Amelie Montel-Hagen et al.
CELL STEM CELL (2019)
Off-the-shelf cell therapy with induced pluripotent stem cell-derived natural killer cells
Michelle L. Saetersmoen et al.
SEMINARS IN IMMUNOPATHOLOGY (2019)
γδ T cells in cancer: a small population of lymphocytes with big implications
Mathilde Raverdeau et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2019)
Cord blood NK cells engineered to express IL-15 and a CD19-targeted CAR show long-term persistence and potent antitumor activity
E. Liu et al.
LEUKEMIA (2018)
The Generation of Human γδT Cell-Derived Induced Pluripotent Stem Cells from Whole Peripheral Blood Mononuclear Cell Culture
Daisuke Watanabe et al.
STEM CELLS TRANSLATIONAL MEDICINE (2018)
Human iPSC-Derived Natural Killer Cells Engineered with Chimeric Antigen Receptors Enhance Anti-tumor Activity
Ye Li et al.
CELL STEM CELL (2018)
A guide to manufacturing CAR T cell therapies
Philipp Vormittag et al.
CURRENT OPINION IN BIOTECHNOLOGY (2018)
Unconventional T Cell Targets for Cancer Immunotherapy
Dale I. Godfrey et al.
IMMUNITY (2018)
Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia
Joseph A. Fraietta et al.
NATURE MEDICINE (2018)
Enumeration, functional responses and cytotoxic capacity of MAIT cells in newly diagnosed and relapsed multiple myeloma
Nicholas A. Gherardin et al.
SCIENTIFIC REPORTS (2018)
Reducing Ex Vivo Culture Improves the Antileukemic Activity of Chimeric Antigen Receptor (CAR) T Cells
Saba Ghassemi et al.
CANCER IMMUNOLOGY RESEARCH (2018)
The Role of Natural Killer T Cells in Cancer-A Phenotypical and Functional Approach
Danielle Krijgsman et al.
FRONTIERS IN IMMUNOLOGY (2018)
Human γδ T-Cells: From Surface Receptors to the Therapy of High-Risk Leukemias
Vito Pistoia et al.
FRONTIERS IN IMMUNOLOGY (2018)
New Insights Into the Regulation of γδ T Cells by BTN3A and Other BTN/BTNL in Tumor Immunity
Juan-Luis Blazquez et al.
FRONTIERS IN IMMUNOLOGY (2018)
IL-21 Selectively Protects CD62L+ NKT Cells and Enhances Their Effector Functions for Adoptive Immunotherapy
Ho Ngai et al.
JOURNAL OF IMMUNOLOGY (2018)
Tumor Antigen Escape from CAR T-cell Therapy
Robbie G. Majzner et al.
CANCER DISCOVERY (2018)
Emerging Cellular Therapies for Cancer
Sonia Guedan et al.
Annual Review of Immunology (2018)
Enhancing T Cell Receptor Stability in Rejuvenated iPSC-Derived T Cells Improves Their Use in Cancer Immunotherapy
Atsutaka Minagawa et al.
CELL STEM CELL (2018)
Strategies for Enhancing and Preserving Anti-leukemia Effects Without Aggravating Graft-Versus-Host Disease
Ying-Jun Chang et al.
FRONTIERS IN IMMUNOLOGY (2018)
Preliminary Data on Safety, Cellular Kinetics and Anti-Leukemic Activity of UCART19, an Allogeneic Anti-CD19 CAR T-Cell Product, in a Pool of Adult and Pediatric Patients with High-Risk CD19+Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia
Reuben Benjamin et al.
BLOOD (2018)
'Off-the-shelf' immunotherapy with iPSC-derived rejuvenated cytotoxic T lymphocytes
Miki Ando et al.
EXPERIMENTAL HEMATOLOGY (2017)
Integration of a CD19 CAR into the. TCR Alpha Chain Locus Streamlines Production of Allogeneic Gene-Edited CAR T Cells
Daniel T. MacLeod et al.
MOLECULAR THERAPY (2017)
HLA-E-expressing pluripotent stem cells escape allogeneic responses and lysis by NK cells
German G. Gornalusse et al.
NATURE BIOTECHNOLOGY (2017)
Generation of mature T cells from human hematopoietic stem and progenitor cells in artificial thymic organoids
Christopher S. Seet et al.
NATURE METHODS (2017)
Molecular remission of infant B-ALL after infusion of universal TALEN gene-edited CAR T cells
Waseem Qasim et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
NK cell-based immunotherapy for cancer
Fang Fang et al.
SEMINARS IN IMMUNOLOGY (2017)
Generation of Off-the-Shelf Natural Killer Cells from Peripheral Blood Cell-Derived Induced Pluripotent Stem Cells
Jieming Zeng et al.
STEM CELL REPORTS (2017)
Shared and Distinct Phenotypes and Functions of Human CD161++ Vα7.2+T Cell Subsets
Ayako Kurioka et al.
FRONTIERS IN IMMUNOLOGY (2017)
Invariant Natural Killer T Cells As Suppressors of Graft-versus-Host Disease in Allogeneic Hematopoietic Stem Cell Transplantation
Melissa Mavers et al.
Frontiers in Immunology (2017)
Antigen receptor-redirected T cells derived from hematopoietic precursor cells lack expression of the endogenous TCR/CD3 receptor and exhibit specific antitumor capacities
Yasmine Van Caeneghem et al.
ONCOIMMUNOLOGY (2017)
Next-Generation Chimeric Antigen Receptor T-Cell Therapy: Going off the Shelf
Marco Ruella et al.
BIODRUGS (2017)
Clinical development of CAR T cells-challenges and opportunities in translating innovative treatment concepts
Jessica Hartmann et al.
EMBO MOLECULAR MEDICINE (2017)
Current Use and Trends in Hematopoietic Cell Transplantation in the United States
Anita D'Souza et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2017)
Adoptive Transfer of Invariant NKT Cells as Immunotherapy for Advanced Melanoma: A Phase I Clinical Trial
Mark A. Exley et al.
CLINICAL CANCER RESEARCH (2017)
Induced Pluripotent Stem Cell-Derived Natural Killer Cells for Treatment of Ovarian Cancer
David L. Hermanson et al.
STEM CELLS (2016)
Armored CAR T-cells: utilizing cytokines and pro-inflammatory ligands to enhance CAR T-cell anti-tumour efficacy
Oladapo O. Yeku et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2016)
Invariant natural killer T cells in hematopoietic stem cell transplantation: killer choice for natural suppression
P. Guan et al.
BONE MARROW TRANSPLANTATION (2016)
Allogeneic Stem Cell Transplantation: A Historical and Scientific Overview
Anurag K. Singh et al.
CANCER RESEARCH (2016)
CD62L+ NKT cells have prolonged persistence and antitumor activity in vivo
Gengwen Tian et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia
Rizwan Romee et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Efficient Regeneration of Human Vα24+ Invariant Natural Killer T Cells and Their Anti-Tumor Activity In Vivo
Daisuke Yamada et al.
STEM CELLS (2016)
Cellular Adjuvant Properties, Direct Cytotoxicity of Re-differentiated Vα24 Invariant NKT-like Cells from Human Induced Pluripotent Stem Cells
Shuichi Kitayama et al.
STEM CELL REPORTS (2016)
Circulating and tumor-infiltrating mucosal associated invariant T (MAIT) cells in colorectal cancer patients
Limian Ling et al.
SCIENTIFIC REPORTS (2016)
Increased tumor infiltration by mucosal-associated invariant T cells correlates with poor survival in colorectal cancer patients
Luciane Zabijak et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2015)
The promise of γδ T cells and the γδ T cell receptor for cancer immunotherapy
Mateusz Legut et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2015)
The burgeoning family of unconventional T cells
Dale I. Godfrey et al.
NATURE IMMUNOLOGY (2015)
Genetic engineering of hematopoietic stem cells to generate invariant natural killer T cells
Drake J. Smith et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Adoptive cell transfer as personalized immunotherapy for human cancer
Steven A. Rosenberg et al.
SCIENCE (2015)
Present and future of allogeneic natural killer cell therapy
Okjae Lim et al.
FRONTIERS IN IMMUNOLOGY (2015)
A Pilot Trial Using Lymphocytes Genetically Engineered with an NY-ESO-1-Reactive T-cell Receptor: Long-term Follow-up and Correlates with Response
Paul F. Robbins et al.
CLINICAL CANCER RESEARCH (2015)
Invariant NKT cells with chimeric antigen receptor provide a novel platform for safe and effective cancer immunotherapy
Andras Heczey et al.
BLOOD (2014)
In vitro generation of mature, naive antigen-specific CD8 + T cells with a single T-cell receptor by agonist selection
S. Snauwaert et al.
LEUKEMIA (2014)
Cancer Immunotherapy Based on Mutation-Specific CD4+T Cells in a Patient with Epithelial Cancer
Eric Tran et al.
SCIENCE (2014)
Gene-modified hematopoietic stem cells for cancer immunotherapy
Sarah Larson et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2014)
Toward eliminating HLA class I expression to generate universal cells from allogeneic donors
Hiroki Torikai et al.
BLOOD (2013)
Toward the realization of cell therapy The advent of MAIT cells from iPSCs
Hiroshi Wakao et al.
CELL CYCLE (2013)
Regeneration of Human Tumor Antigen-Specific T Cells from iPSCs Derived from Mature CD8+ T Cells
Raul Vizcardo et al.
CELL STEM CELL (2013)
Generation of Rejuvenated Antigen-Specific T Cells by Reprogramming to Pluripotency and Redifferentiation
Toshinobu Nishimura et al.
CELL STEM CELL (2013)
Expansion of Functional Human Mucosal-Associated Invariant T Cells via Reprogramming to Pluripotency and Redifferentiation
Hiroshi Wakao et al.
CELL STEM CELL (2013)
Allelic Exclusion and Peripheral Reconstitution by TCR Transgenic T Cells Arising From Transduced Human Hematopoietic Stem/Progenitor Cells
Francesca Giannoni et al.
MOLECULAR THERAPY (2013)
Introduction of Exogenous T-cell Receptors Into Human Hematopoietic Progenitors Results in Exclusion of Endogenous T-cell Receptor Expression
Dimitrios N. Vatakis et al.
MOLECULAR THERAPY (2013)
Generation of tumor-targeted human T lymphocytes from induced pluripotent stem cells for cancer therapy
Maria Themeli et al.
NATURE BIOTECHNOLOGY (2013)
The Basic Principles of Chimeric Antigen Receptor Design
Michel Sadelain et al.
CANCER DISCOVERY (2013)
Clinical-Scale Derivation of Natural Killer Cells From Human Pluripotent Stem Cells for Cancer Therapy
David A. Knorr et al.
STEM CELLS TRANSLATIONAL MEDICINE (2013)
NKT cells as an ideal anti-tumor immunotnerapeutic
Shin-ichiro Fujii et al.
FRONTIERS IN IMMUNOLOGY (2013)
Graft invariant natural killer T-cell dose predicts risk of acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation
Aristeidis Chaidos et al.
BLOOD (2012)
A foundation for universal T-cell based immunotherapy: T cells engineered to express a CD19-specific chimeric-antigen-receptor and eliminate expression of endogenous TCR
Hiroki Torikai et al.
BLOOD (2012)
Adoptive T-Cell Therapy Using Autologous Tumor-Infiltrating Lymphocytes for Metastatic Melanoma Current Status and Future Outlook
Richard Wu et al.
CANCER JOURNAL (2012)
Graft versus Host Disease in the Bone Marrow, Liver and Thymus Humanized Mouse Model
Matthew B. Greenblatt et al.
PLOS ONE (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Induction of NKT cell-specific immune responses in cancer tissues after NKT cell-targeted adoptive immunotherapy
Kazuki Yamasaki et al.
CLINICAL IMMUNOLOGY (2011)
Development of Defective and Persistent Sendai Virus Vector A UNIQUE GENE DELIVERY/EXPRESSION SYSTEM IDEAL FOR CELL REPROGRAMMING
Ken Nishimura et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Human Pluripotent Stem Cells Produce Natural Killer Cells That Mediate Anti-HIV-1 Activity by Utilizing Diverse Cellular Mechanisms
Zhenya Ni et al.
JOURNAL OF VIROLOGY (2011)
Isolation of Single Human Hematopoietic Stem Cells Capable of Long-Term Multilineage Engraftment
Faiyaz Notta et al.
SCIENCE (2011)
Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
Robert D. Schreiber et al.
SCIENCE (2011)
Invariant NKT cells modulate the suppressive activity of IL-10-secreting neutrophils differentiated with serum amyloid A
Carmela De Santo et al.
NATURE IMMUNOLOGY (2010)
Notch-mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitution
Colleen Delaney et al.
NATURE MEDICINE (2010)
Generation of functional human T-cell subsets with HLA-restricted immune responses in HLA class I expressing NOD/SCID/IL2rγnull humanized mice
Leonard D. Shultz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Human embryonic stem cells differentiate into a homogeneous population of natural killer cells with potent in vivo antitumor activity
Petter S. Woll et al.
BLOOD (2009)
Human γδ T Cells: A Lymphoid Lineage Cell Capable of Professional Phagocytosis
Yin Wu et al.
JOURNAL OF IMMUNOLOGY (2009)
Graft-versus-host disease
James L. M. Ferrara et al.
LANCET (2009)
Engineering Antigen-Specific T Cells from Genetically Modified Human Hematopoietic Stem Cells in Immunodeficient Mice
Scott G. Kitchen et al.
PLOS ONE (2009)
Cross-presenting human γδ T cells induce robust CD8+ αβ T cell responses
Marlene Brandes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Generation of functional platelets from human embryonic stem cells in vitro via ES-sacs, VEGF-promoted structures that concentrate hematopoietic progenitors
Naoya Takayama et al.
BLOOD (2008)
Induction of pluripotent stem cells from adult human fibroblasts by defined factors
Kazutoshi Takahashi et al.
CELL (2007)
Generation of pro-T cells in vitro:: potential for immune reconstitution
Geneve Awong et al.
SEMINARS IN IMMUNOLOGY (2007)
Characterization of human invariant natural killer T subsets in health and disease using a novel invariant natural killer T cell-clonotypic monoclonal antibody, 6B11
Carlos J. Montoya et al.
IMMUNOLOGY (2007)
Hierarchy of Notch-Delta interactions promoting T cell lineage commitment and maturation
Valerie Besseyrias et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1
Michael W. Melkus et al.
NATURE MEDICINE (2006)
A phase I study of in vitro expanded natural killer T cells in patients with advanced and recurrent non-small cell lung cancer
Shinichiro Motohashi et al.
CLINICAL CANCER RESEARCH (2006)
Reconstitution of a functional human immune system in immunodeficient mice through combined human fetal thymus/liver and CD34+ cell transplantation
Ping Lan et al.
BLOOD (2006)
Stage-specific and differential notch dependency at the αβ and γδ T lineage bifurcation
Maria Ciofani et al.
IMMUNITY (2006)
Human embryonic stem cell-derived NK cells acquire functional receptors and cytolytic activity
PS Woll et al.
JOURNAL OF IMMUNOLOGY (2005)
Human embryonic stem cell-derived CD34+ cells:: efficient production in the coculture with OP9 stromal cells and analysis of lymphohematopoietic potential
MA Vodyanik et al.
BLOOD (2005)
Notch promotes survival of pre-T cells at the beta-selection checkpoint by regulating cellular metabolism
M Ciofani et al.
NATURE IMMUNOLOGY (2005)
Adoptive-cell-transfer therapy for the treatment of patients with cancer
ME Dudley et al.
NATURE REVIEWS CANCER (2003)
Induction of T cell development from hematopoietic progenitor cells by delta-like-1 in vitro
TM Schmitt et al.
IMMUNITY (2002)
Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining
JE Gumperz et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Share Paper
